CVE-2025-52653
Essential information
- Published
- 03/10/2025 18:15
- Modified
- 03/10/2025 18:15
- Author
- —
- Creator
- —
- CVSS
- 7.6 HIGH (v3.1)
- CISA KEV
- No
- CWE
- —
- CVSS vector
-
—
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H—
CVSS metrics
- Access vector
- —
- Access complexity
- —
- Authentication
- —
- Confidentiality impact
- —
- Integrity impact
- —
- Availability impact
- —
- Exploitability
- —
- Remediation level
- —
- Report confidence
- —
- Temporal score
- —
- Attack vector
- NETWORK
- Attack complexity
- LOW
- Privileges required
- LOW
- User interaction
- REQUIRED
- Scope
- UNCHANGED
- Confidentiality impact
- HIGH
- Integrity impact
- LOW
- Availability impact
- HIGH
- Exploit code maturity
- —
- Remediation level
- —
- Report confidence
- —
- Temporal score
- —
- Attack vector
- —
- Attack complexity
- —
- Attack requirements
- —
- Privileges required
- —
- User interaction
- —
- Confidentiality (V)
- —
- Confidentiality (S)
- —
- Integrity (V)
- —
- Integrity (S)
- —
- Availability (V)
- —
- Availability (S)
- —
- Exploit maturity
- —
Description
HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.
NVD status
- Status
- Received — CVE has been recently published to the CVE List and has been received by the NVD.
- Source
- [email protected]
- NVD
- View on NVD
Affected products (CPE)
| Product | CPE |
|---|---|
| hcl / hcl myxalytics | cpe:2.3:a:hcl:hcl_myxalytics:*:*:*:*:*:*:*:* |